Vanderbilt University Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).
Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.
Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.
Top-decile sponsor footprint
Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
677 total, page 2 of 14
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
NCT06576726
The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings
NCT06546696
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
NCT05856994
Sleep Coach for Adolescents With Type 1 Diabetes
NCT06516614
Neurophysiology of Reward Signaling in Parkinson's Disease
NCT07409207
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
NCT06479876
Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency
NCT06456762
The APS Phenotyping Study
NCT06521502
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
NCT06093100
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
NCT06427538
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
NCT06338553
Respiratory Strength Training in Heart Transplant Recipients
NCT06190171
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
NCT06299683
Long COVID Immune Profiling
NCT06027255
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
NCT06124196
Tranexamic Acid in Nasal Mohs Reconstruction
NCT06057675
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
NCT04941599
Retinal Vascular Changes During Pregnancy
NCT06311617
Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy
NCT06202443
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
NCT06077201
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
NCT06647459
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
NCT06575881
Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor
NCT05834777
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
NCT04469842
Treating Exacerbations of Asthma With Oral Montelukast in Children
NCT05819541
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
NCT05988710
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
NCT05288790
Assessment of the Ocular Microbiome in Health and Disease
NCT05414994
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
NCT05972564
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
NCT05999630
Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers
NCT05880225
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
NCT05422534
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
NCT05812755
Depressed Mood Improvement Through Nicotine Dosing 3
NCT05746273
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis
NCT05774717
VZV in the Enteric Nervous System: Pathogenesis and Consequences
NCT05550194
Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation
NCT05650710
Splanchnic Venous Capacitance in Postural Tachycardia Syndrome
NCT05375968
3D Specimen Maps for RT Planning
NCT05743569
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
NCT05357612
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
NCT05462574
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
NCT05464095
MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing
NCT05505110
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
NCT05215327
Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA
NCT05501236
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
NCT05584722
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
NCT05254314
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967
CPAP for the Treatment of Supine Hypertension
NCT05489575
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 65 |
| Phase 2 | 62 |
| Phase 3 | 14 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the Vanderbilt University Medical Center pipeline
130 recruiting of 677 indexed (19% open); 400 completed (59%).
Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).
Top condition: Autonomic Failure (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University Medical Center: open-pipeline peers nationwide
Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 677 trials (± recruiting share)
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of California, Davis · 657 trials · 19% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Mayo Clinic · 19% recruiting · 2,844 trials
- University of South Carolina · 19% recruiting · 157 trials
Related
What to do with this Vanderbilt University Medical Center page
677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.
- 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets.Report a data error.